Amarin Corporation Plc (AMRN) 3.03 $AMRN Premar
Post# of 64068
Posted On: 03/16/2015 1:31:21 PM
Amarin Corporation Plc (AMRN) 3.03 $AMRN
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Mon Mar 16, 8:14AM CDT
KNDI: 14.36 (+1.13), WLL: 37.69 (-2.31), ADXS: 14.22 (+1.81), LTM: 70.62 (+3.42), MVIS: 3.16 (+0.42), AMRN: 3.03 (+0.13), MTL: 1.05 (-0.49), FXCM: 2.40 (-0.18), CTIC: 1.97 (unch), DSKY: 7.71 (-3.11)
Amarin up premarket
Seeking Alpha - at Seeking Alpha - Mon Mar 16, 7:41AM CDT
AMRN: 3.03 (+0.13)
Amarin Upgrade Signals Start Of A Long-Term Run-Up
Clinically Sound Investor - at Seeking Alpha - Fri Mar 13, 4:10PM CDT
AMRN: 3.03 (+0.13)
3 Biotech Stocks on Traders' Radars: Technical Charts
at The Street - Fri Mar 13, 2:06PM CDT
Here's how to trade some of the most active biotech stocks on the market today.
AMRN: 3.03 (+0.13), GALE: 1.39 (-0.03), CTIC: 1.97 (unch)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Mar 13, 11:45AM CDT
RXII: 1.20 (+0.05), QADA: 24.43 (-0.44), AMRN: 3.03 (+0.13), FXCM: 2.40 (-0.18), CTIC: 1.97 (unch), ARO: 2.93 (-0.13), GBR: 1.74 (+0.11), RGEN: 31.12 (-0.19), AMTX: 3.91 (-0.34), IRG: 5.61 (-0.29), EVAR: 4.20 (+0.05), QTWW: 2.42 (-0.13), CTRN: 24.50 (+0.77), CVEO: 2.82 (-0.10), LOCO: 26.71 (-0.39), GALE: 1.39 (-0.03), EBIX: 28.81 (-0.74), ANAC: 56.74 (+1.08), EMAN: 2.56 (unch), SHOS: 9.49 (+0.37)
Biotech Stock Mailbag: Neuralstem, Genfit, Intercept, Amarin
at The Street - Fri Mar 13, 8:00AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.
AMRN: 3.03 (+0.13), ICPT: 295.72 (+14.34), CUR: 2.41 (-0.15)
Traders Get Bullish on Shares of Amarin, Shares Up 25.8% (AMRN)
Comtex SmarTrend(R) - Thu Mar 12, 12:50PM CDT
Amarin (NASDAQ:AMRN) is one of today's best performing low-priced stocks, up 25.8% to $2.44 on 7.6x average daily volume. Amarin has traded 20.0 million shares thus far today, vs. average volume of 2.6 million shares per day. The stock has outperformed the Dow (25.8% to the Dow's 1.1%) and outperformed the S&P 500 (25.8% to the S&P's 0.9%) during today's trading.
AMRN: 3.03 (+0.13)
Why Amarin Corporation plc Blasted Higher
George Budwell, The Motley Fool - Motley Fool - Thu Mar 12, 10:26AM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What : Shares of the small-cap biopharma Amarin Corp. ...
AMRN: 3.03 (+0.13)
Upgrade Alert for Amarin (AMRN)
Comtex SmarTrend(R) - Thu Mar 12, 8:47AM CDT
Amarin (NASDAQ:AMRN) was upgraded from Neutral to Buy at H.C. Wainwright today. The stock closed yesterday at $1.94 on volume of 5.5 million shares, above average daily volume of 2.6 million. Amarin Corporation PLC is a clinical-stage biopharmaceutical company. The Company researches, develops, and commercializes drugs for the treatment of hypertriglyceridemia, central nervous system disorders, and cardiovascular diseases.
AMRN: 3.03 (+0.13)
After Hours Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Mar 11, 4:36PM CDT
ZOES: 35.28 (+0.39), ACAD: 33.83 (-0.62), SHAK: 47.54 (-0.96), BOX: 17.25 (-0.63), MW: 51.44 (-0.26), PQ: 1.99 (-0.03), AMRN: 3.03 (+0.13), SCLN: 8.81 (+0.14), KKD: 19.53 (+0.21), MS: 36.40 (+0.05)
Amarin: The Effect Of The Private Placement Deal
Elephant Analytics - at Seeking Alpha - Tue Mar 10, 4:04PM CDT
AMRN: 3.03 (+0.13)
Market Shrugs Off Amarin's New Financing
Clinically Sound Investor - at Seeking Alpha - Mon Mar 09, 10:03PM CDT
AMRN: 3.03 (+0.13)
Hot Stock: Amarin, Shares Gain 6.7% (AMRN)
Comtex SmarTrend(R) - Mon Mar 09, 11:45AM CDT
Amarin (NASDAQ:AMRN) is one of today's best performing low-priced stocks, up 6.7% to $1.90 on 1.5x average daily volume. Amarin has traded 3.5 million shares thus far today, vs. average volume of 2.4 million shares per day. The stock has outperformed the Dow (6.7% to the Dow's 0.7%) and outperformed the S&P 500 (6.7% to the S&P's 0.3%) during today's trading.
AMRN: 3.03 (+0.13)
Amarin expects USD52.8m from private placement of restricted American Depositary Shares
M2 - Mon Mar 09, 5:46AM CDT
Biopharmaceutical company Amarin Corporation plc (NasdaqGM:AMRN) Friday announced a definitive securities subscription agreement with a group of existing and new investors for the private placement of up to a maximum of USD52.823m of restricted American depositary shares.
AMRN: 3.03 (+0.13)
Why Amarin Corporation PLC Soared 48% in February
Sean Williams, The Motley Fool - Motley Fool - Fri Mar 06, 7:01AM CST
What: Shares of Amarin , a biopharmaceutical company focused on developing therapies to address treatments for cardiovascular diseases, soared 48% in February per S&P Capital IQ data after receiving a very generous upgrade from a Wall Street...
AMRN: 3.03 (+0.13)
Amarin secures $52.8M in new capital
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 6:16AM CST
AMRN: 3.03 (+0.13)
Amarin: Modeling Its Cash Balance Trajectory To 2017
Elephant Analytics - at Seeking Alpha - Thu Mar 05, 7:28AM CST
AMRN: 3.03 (+0.13)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Mon Mar 16, 8:14AM CDT
KNDI: 14.36 (+1.13), WLL: 37.69 (-2.31), ADXS: 14.22 (+1.81), LTM: 70.62 (+3.42), MVIS: 3.16 (+0.42), AMRN: 3.03 (+0.13), MTL: 1.05 (-0.49), FXCM: 2.40 (-0.18), CTIC: 1.97 (unch), DSKY: 7.71 (-3.11)
Amarin up premarket
Seeking Alpha - at Seeking Alpha - Mon Mar 16, 7:41AM CDT
AMRN: 3.03 (+0.13)
Amarin Upgrade Signals Start Of A Long-Term Run-Up
Clinically Sound Investor - at Seeking Alpha - Fri Mar 13, 4:10PM CDT
AMRN: 3.03 (+0.13)
3 Biotech Stocks on Traders' Radars: Technical Charts
at The Street - Fri Mar 13, 2:06PM CDT
Here's how to trade some of the most active biotech stocks on the market today.
AMRN: 3.03 (+0.13), GALE: 1.39 (-0.03), CTIC: 1.97 (unch)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Mar 13, 11:45AM CDT
RXII: 1.20 (+0.05), QADA: 24.43 (-0.44), AMRN: 3.03 (+0.13), FXCM: 2.40 (-0.18), CTIC: 1.97 (unch), ARO: 2.93 (-0.13), GBR: 1.74 (+0.11), RGEN: 31.12 (-0.19), AMTX: 3.91 (-0.34), IRG: 5.61 (-0.29), EVAR: 4.20 (+0.05), QTWW: 2.42 (-0.13), CTRN: 24.50 (+0.77), CVEO: 2.82 (-0.10), LOCO: 26.71 (-0.39), GALE: 1.39 (-0.03), EBIX: 28.81 (-0.74), ANAC: 56.74 (+1.08), EMAN: 2.56 (unch), SHOS: 9.49 (+0.37)
Biotech Stock Mailbag: Neuralstem, Genfit, Intercept, Amarin
at The Street - Fri Mar 13, 8:00AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.
AMRN: 3.03 (+0.13), ICPT: 295.72 (+14.34), CUR: 2.41 (-0.15)
Traders Get Bullish on Shares of Amarin, Shares Up 25.8% (AMRN)
Comtex SmarTrend(R) - Thu Mar 12, 12:50PM CDT
Amarin (NASDAQ:AMRN) is one of today's best performing low-priced stocks, up 25.8% to $2.44 on 7.6x average daily volume. Amarin has traded 20.0 million shares thus far today, vs. average volume of 2.6 million shares per day. The stock has outperformed the Dow (25.8% to the Dow's 1.1%) and outperformed the S&P 500 (25.8% to the S&P's 0.9%) during today's trading.
AMRN: 3.03 (+0.13)
Why Amarin Corporation plc Blasted Higher
George Budwell, The Motley Fool - Motley Fool - Thu Mar 12, 10:26AM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What : Shares of the small-cap biopharma Amarin Corp. ...
AMRN: 3.03 (+0.13)
Upgrade Alert for Amarin (AMRN)
Comtex SmarTrend(R) - Thu Mar 12, 8:47AM CDT
Amarin (NASDAQ:AMRN) was upgraded from Neutral to Buy at H.C. Wainwright today. The stock closed yesterday at $1.94 on volume of 5.5 million shares, above average daily volume of 2.6 million. Amarin Corporation PLC is a clinical-stage biopharmaceutical company. The Company researches, develops, and commercializes drugs for the treatment of hypertriglyceridemia, central nervous system disorders, and cardiovascular diseases.
AMRN: 3.03 (+0.13)
After Hours Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Mar 11, 4:36PM CDT
ZOES: 35.28 (+0.39), ACAD: 33.83 (-0.62), SHAK: 47.54 (-0.96), BOX: 17.25 (-0.63), MW: 51.44 (-0.26), PQ: 1.99 (-0.03), AMRN: 3.03 (+0.13), SCLN: 8.81 (+0.14), KKD: 19.53 (+0.21), MS: 36.40 (+0.05)
Amarin: The Effect Of The Private Placement Deal
Elephant Analytics - at Seeking Alpha - Tue Mar 10, 4:04PM CDT
AMRN: 3.03 (+0.13)
Market Shrugs Off Amarin's New Financing
Clinically Sound Investor - at Seeking Alpha - Mon Mar 09, 10:03PM CDT
AMRN: 3.03 (+0.13)
Hot Stock: Amarin, Shares Gain 6.7% (AMRN)
Comtex SmarTrend(R) - Mon Mar 09, 11:45AM CDT
Amarin (NASDAQ:AMRN) is one of today's best performing low-priced stocks, up 6.7% to $1.90 on 1.5x average daily volume. Amarin has traded 3.5 million shares thus far today, vs. average volume of 2.4 million shares per day. The stock has outperformed the Dow (6.7% to the Dow's 0.7%) and outperformed the S&P 500 (6.7% to the S&P's 0.3%) during today's trading.
AMRN: 3.03 (+0.13)
Amarin expects USD52.8m from private placement of restricted American Depositary Shares
M2 - Mon Mar 09, 5:46AM CDT
Biopharmaceutical company Amarin Corporation plc (NasdaqGM:AMRN) Friday announced a definitive securities subscription agreement with a group of existing and new investors for the private placement of up to a maximum of USD52.823m of restricted American depositary shares.
AMRN: 3.03 (+0.13)
Why Amarin Corporation PLC Soared 48% in February
Sean Williams, The Motley Fool - Motley Fool - Fri Mar 06, 7:01AM CST
What: Shares of Amarin , a biopharmaceutical company focused on developing therapies to address treatments for cardiovascular diseases, soared 48% in February per S&P Capital IQ data after receiving a very generous upgrade from a Wall Street...
AMRN: 3.03 (+0.13)
Amarin secures $52.8M in new capital
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 6:16AM CST
AMRN: 3.03 (+0.13)
Amarin: Modeling Its Cash Balance Trajectory To 2017
Elephant Analytics - at Seeking Alpha - Thu Mar 05, 7:28AM CST
AMRN: 3.03 (+0.13)
(0)
(0)